{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:04:20Z","timestamp":1791180260782,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T00:00:00Z","timestamp":1412899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T00:00:00Z","timestamp":1412899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2014.70","type":"journal-article","created":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T13:18:36Z","timestamp":1412947116000},"page":"XX-XX","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma"],"prefix":"10.1038","volume":"4","author":[{"given":"F","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-C","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-H","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-C","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-P","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P-N","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-W","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L-T","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-L","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C S J","family":"Fann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-T","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-S","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,10]]},"reference":[{"key":"BFbcj201470_CR1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/0016-5085(91)90063-Q","volume":"101","author":"SB Cogliatti","year":"1991","unstructured":"Cogliatti SB, Schmid U, Schumacher U, Eckert F, Hansmann ML, Hedderich J et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology 1991; 101: 1159\u20131170.","journal-title":"Gastroenterology"},{"key":"BFbcj201470_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/modpathol.3800028","volume":"17","author":"ES Jaffe","year":"2004","unstructured":"Jaffe ES, Banks PM, Nathwani B, Said J, Swerdlow SH . Recommendations for the reporting of lymphoid neoplasms: a report from the Association of Directors of Anatomic and Surgical Pathology. Mod Pathol 2004; 17: 131\u2013135.","journal-title":"Mod Pathol"},{"key":"BFbcj201470_CR3","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrc1409","volume":"4","author":"PG Isaacson","year":"2004","unstructured":"Isaacson PG, Du MQ . MALT lymphoma: from morphology to molecules. Nat Rev Cancer 2004; 4: 644\u2013653.","journal-title":"Nat Rev Cancer"},{"key":"BFbcj201470_CR4","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","volume":"338","author":"AC Wotherspoon","year":"1991","unstructured":"Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG . Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175\u20131176.","journal-title":"Lancet"},{"key":"BFbcj201470_CR5","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1056\/NEJM199803193381205","volume":"338","author":"E Zucca","year":"1998","unstructured":"Zucca E, Bertoni F, Roggero E, Bosshard G, Cazzaniga G, Pedrinis E et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 1998; 338: 804\u2013810.","journal-title":"N Engl J Med"},{"key":"BFbcj201470_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.7326\/0003-4819-122-10-199505150-00006","volume":"122","author":"E Roggero","year":"1995","unstructured":"Roggero E, Zucca E, Pinotti G, Pascarella A, Capella C, Savio A et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995; 122: 767\u2013769.","journal-title":"Ann Intern Med"},{"key":"BFbcj201470_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","volume":"8","author":"A Zullo","year":"2010","unstructured":"Zullo A, Hassan C, Cristofari F, Andriani A, De Francesco V, Ierardi E et al. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 2010; 8: 105\u2013110.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BFbcj201470_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/gut.36.3.341","volume":"36","author":"R Karttunen","year":"1995","unstructured":"Karttunen R, Karttunen T, Ekre HP, MacDonald TT . Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 1995; 36: 341\u2013345.","journal-title":"Gut"},{"key":"BFbcj201470_CR9","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1128\/IAI.66.11.5543-5546.1998","volume":"66","author":"F Sommer","year":"1998","unstructured":"Sommer F, Faller G, Konturek P, Kirchner T, Hahn EG, Zeus J et al. Antrum- and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun 1998; 66: 5543\u20135546.","journal-title":"Infect Immun"},{"key":"BFbcj201470_CR10","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1523-5378.2011.00861.x","volume":"16","author":"M Obonyo","year":"2011","unstructured":"Obonyo M, Rickman B, Guiney DG . Effects of myeloid differentiation primary response gene 88 (MyD88) activation on Helicobacter infection in vivo and induction of a Th17 response. Helicobacter 2011; 16: 398\u2013404.","journal-title":"Helicobacter"},{"key":"BFbcj201470_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1128\/IAI.00524-09","volume":"78","author":"W Khamri","year":"2010","unstructured":"Khamri W, Walker MM, Clark P, Atherton JC, Thursz MR, Bamford KB et al. Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infect Immun 2010; 78: 845\u2013853.","journal-title":"Infect Immun"},{"key":"BFbcj201470_CR12","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.3748\/wjg.v13.i42.5547","volume":"13","author":"R Caruso","year":"2007","unstructured":"Caruso R, Pallone F, Monteleone G . Emerging role of IL-23\/IL-17 axis in H pylori-associated pathology. World J Gastroenterol 2007; 13: 5547\u20135551.","journal-title":"World J Gastroenterol"},{"key":"BFbcj201470_CR13","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/annonc\/mdg442","volume":"14","author":"MD Aljurf","year":"2003","unstructured":"Aljurf MD, Owaidah TW, Ezzat A, Ibrahim E, Tbakhi A . Antigen- and\/or immune-driven lymphoproliferative disorders. Ann Oncol 2003; 14: 1595\u20131606.","journal-title":"Ann Oncol"},{"key":"BFbcj201470_CR14","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1182\/blood-2005-09-3679","volume":"107","author":"F Suarez","year":"2006","unstructured":"Suarez F, Lortholary O, Hermine O, Lecuit M . Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 2006; 107: 3034\u20133044.","journal-title":"Blood"},{"key":"BFbcj201470_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1046\/j.1440-1746.2002.02770.x","volume":"17","author":"J Houghton","year":"2002","unstructured":"Houghton J, Fox JG, Wang TC . Gastric cancer: laboratory bench to clinic. J Gastroenterol Hepatol 2002; 17: 495\u2013502.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFbcj201470_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00284-009-9518-4","volume":"60","author":"TB Romero-Adrian","year":"2010","unstructured":"Romero-Adrian TB, Leal-Montiel J, Monsalve-Castillo F, Mengual-Moreno E, McGregor EG, Perini L et al. Helicobacter pylori: bacterial factors and the role of cytokines in the immune response. Curr Microbiol 2010; 60: 143\u2013155.","journal-title":"Curr Microbiol"},{"key":"BFbcj201470_CR17","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1158\/1055-9965.EPI-04-0792","volume":"14","author":"MS Wu","year":"2005","unstructured":"Wu MS, Chen CJ, Lin JT . Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1878\u20131882.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFbcj201470_CR18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ijc.20199","volume":"110","author":"MS Wu","year":"2004","unstructured":"Wu MS, Chen LT, Shun CT, Huang SP, Chiu HM, Wang HP et al. Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma. Int J Cancer 2004; 110: 695\u2013700.","journal-title":"Int J Cancer"},{"key":"BFbcj201470_CR19","first-page":"1015","volume":"89","author":"MS Wu","year":"2004","unstructured":"Wu MS, Shun CT, Huang SP, Cheng AL, Chen LT, Lin JT . Effect of interleukin-1beta and glutathione S-transferase genotypes on the development of gastric mucosa-associated lymphoid tissue lymphoma. Haematologica 2004; 89: 1015\u20131017.","journal-title":"Haematologica"},{"key":"BFbcj201470_CR20","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1200\/JCO.2005.05.5434","volume":"24","author":"TY Cheng","year":"2006","unstructured":"Cheng TY, Lin JT, Chen LT, Shun CT, Wang HP, Lin MT et al. Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 2006; 24: 3483\u20133489.","journal-title":"J Clin Oncol"},{"key":"BFbcj201470_CR21","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1136\/gut.2008.163667","volume":"58","author":"S Brand","year":"2009","unstructured":"Brand S . Crohn\u2019s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn\u2019s disease. Gut 2009; 58: 1152\u20131167.","journal-title":"Gut"},{"key":"BFbcj201470_CR22","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.yexcr.2010.12.018","volume":"317","author":"T Ito","year":"2011","unstructured":"Ito T, Carson WFt, Cavassani KA, Connett JM, Kunkel SL . CCR6 as a mediator of immunity in the lung and gut. Exp Cell Res 2011; 317: 613\u2013619.","journal-title":"Exp Cell Res"},{"key":"BFbcj201470_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/gast.2001.20914","volume":"120","author":"MB Dwinell","year":"2001","unstructured":"Dwinell MB, Lugering N, Eckmann L, Kagnoff MF . Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterology 2001; 120: 49\u201359.","journal-title":"Gastroenterology"},{"key":"BFbcj201470_CR24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/mi.2009.113","volume":"2","author":"F Marchesi","year":"2009","unstructured":"Marchesi F, Martin AP, Thirunarayanan N, Devany E, Mayer L, Grisotto MG et al. CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles. Mucosal Immunol 2009; 2: 486\u2013494.","journal-title":"Mucosal Immunol"},{"key":"BFbcj201470_CR25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1126\/science.1102901","volume":"307","author":"JH Niess","year":"2005","unstructured":"Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005; 307: 254\u2013258.","journal-title":"Science"},{"key":"BFbcj201470_CR26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1767","volume":"10","author":"T Duhen","year":"2009","unstructured":"Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F . Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009; 10: 857\u2013863.","journal-title":"Nat Immunol"},{"key":"BFbcj201470_CR27","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/ni.1770","volume":"10","author":"S Trifari","year":"2009","unstructured":"Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H . Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 2009; 10: 864\u2013871.","journal-title":"Nat Immunol"},{"key":"BFbcj201470_CR28","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/eji.200535503","volume":"36","author":"K Wolk","year":"2006","unstructured":"Wolk K, Witte E, Wallace E, Docke WD, Kunz S, Asadullah K et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 2006; 36: 1309\u20131323.","journal-title":"Eur J Immunol"},{"key":"BFbcj201470_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nm1720","volume":"14","author":"Y Zheng","year":"2008","unstructured":"Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008; 14: 282\u2013289.","journal-title":"Nat Med"},{"issue":"Suppl 1","key":"BFbcj201470_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1523-5378.2007.00530.x","volume":"12","author":"MM D'Elios","year":"2007","unstructured":"D'Elios MM, Andersen LP . Helicobacter pylori inflammation, immunity, and vaccines. Helicobacter 2007; 12 (Suppl 1): 15\u201319.","journal-title":"Helicobacter"},{"key":"BFbcj201470_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.tim.2010.08.003","volume":"18","author":"S Backert","year":"2010","unstructured":"Backert S, Naumann M . What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori. Trends Microbiol 2010; 18: 479\u2013486.","journal-title":"Trends Microbiol"},{"key":"BFbcj201470_CR32","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.4049\/jimmunol.168.11.5397","volume":"168","author":"K Wolk","year":"2002","unstructured":"Wolk K, Kunz S, Asadullah K, Sabat R . Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol 2002; 168: 5397\u20135402.","journal-title":"J Immunol"},{"key":"BFbcj201470_CR33","doi-asserted-by":"publisher","first-page":"10144","DOI":"10.1073\/pnas.170291697","volume":"97","author":"L Dumoutier","year":"2000","unstructured":"Dumoutier L, Van Roost E, Colau D, Renauld JC . Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. Proc Natl Acad Sci USA 2000; 97: 10144\u201310149.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201470_CR34","doi-asserted-by":"publisher","first-page":"31335","DOI":"10.1074\/jbc.M005304200","volume":"275","author":"MH Xie","year":"2000","unstructured":"Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J et al. Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 2000; 275: 31335\u201331339.","journal-title":"J Biol Chem"},{"key":"BFbcj201470_CR35","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1074\/jbc.M007837200","volume":"276","author":"SV Kotenko","year":"2001","unstructured":"Kotenko SV, Izotova LS, Mirochnitchenko OV, Esterova E, Dickensheets H, Donnelly RP et al. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 2001; 276: 2725\u20132732.","journal-title":"J Biol Chem"},{"key":"BFbcj201470_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","volume":"21","author":"K Wolk","year":"2004","unstructured":"Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R . IL-22 increases the innate immunity of tissues. Immunity 2004; 21: 241\u2013254.","journal-title":"Immunity"},{"key":"BFbcj201470_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nm1710","volume":"14","author":"SJ Aujla","year":"2008","unstructured":"Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008; 14: 275\u2013281.","journal-title":"Nat Med"},{"key":"BFbcj201470_CR38","doi-asserted-by":"publisher","first-page":"33676","DOI":"10.1074\/jbc.M204204200","volume":"277","author":"D Lejeune","year":"2002","unstructured":"Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC . Interleukin-22 (IL-22) activates the JAK\/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem 2002; 277: 33676\u201333682.","journal-title":"J Biol Chem"},{"key":"BFbcj201470_CR39","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/leu.2008.129","volume":"22","author":"JD Bard","year":"2008","unstructured":"Bard JD, Gelebart P, Anand M, Amin HM, Lai R . Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma. Leukemia 2008; 22: 1595\u20131603.","journal-title":"Leukemia"},{"key":"BFbcj201470_CR40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1182\/blood-2010-05-285908","volume":"117","author":"R Savan","year":"2011","unstructured":"Savan R, McFarland AP, Reynolds DA, Feigenbaum L, Ramakrishnan K, Karwan M et al. A novel role for IL-22R1 as a driver of inflammation. Blood 2011; 117: 575\u2013584.","journal-title":"Blood"},{"key":"BFbcj201470_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1593\/tlo.10172","volume":"4","author":"P Gelebart","year":"2011","unstructured":"Gelebart P, Zak Z, Dien-Bard J, Anand M, Lai R . Interleukin 22 signaling promotes cell growth in mantle cell lymphoma. Transl Oncol 2011; 4: 9\u201319.","journal-title":"Transl Oncol"},{"key":"BFbcj201470_CR42","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/j.1478-3231.2007.01518.x","volume":"27","author":"BJ Hennig","year":"2007","unstructured":"Hennig BJ, Frodsham AJ, Hellier S, Knapp S, Yee LJ, Wright M et al. Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection. Liver Int 2007; 27: 1134\u20131143.","journal-title":"Liver Int"},{"key":"BFbcj201470_CR43","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s10552-010-9542-5","volume":"21","author":"CL Thompson","year":"2010","unstructured":"Thompson CL, Plummer SJ, Tucker TC, Casey G, Li L . Interleukin-22 genetic polymorphisms and risk of colon cancer. Cancer Causes Control 2010; 21: 1165\u20131170.","journal-title":"Cancer Causes Control"},{"key":"BFbcj201470_CR44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/srep00020","volume":"1","author":"G Zhang","year":"2011","unstructured":"Zhang G, Chen X, Chan L, Zhang M, Zhu B, Wang L et al. An SNP selection strategy identified IL-22 associating with susceptibility to tuberculosis in Chinese. Sci Rep 2011; 1: 20.","journal-title":"Sci Rep"},{"key":"BFbcj201470_CR45","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1111\/j.1572-0241.2005.00338.x","volume":"100","author":"S Hellmig","year":"2005","unstructured":"Hellmig S, Fischbach W, Goebeler-Kolve ME, Folsch UR, Hampe J, Schreiber S . A functional promotor polymorphism of TNF-alpha is associated with primary gastric B-Cell lymphoma. Am J Gastroenterol 2005; 100: 2644\u20132649.","journal-title":"Am J Gastroenterol"},{"key":"BFbcj201470_CR46","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1182\/blood-2004-05-1792","volume":"104","author":"S Hellmig","year":"2004","unstructured":"Hellmig S, Vollenberg S, Goebeler-Kolve ME, Fischbach W, Hampe J, Folsch UR et al. IL-1 gene cluster polymorphisms and development of primary gastric B-cell lymphoma in Helicobacter pylori infection. Blood 2004; 104: 2994\u20132995.","journal-title":"Blood"},{"key":"BFbcj201470_CR47","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s10620-008-0231-0","volume":"53","author":"S Hellmig","year":"2008","unstructured":"Hellmig S, Bartscht T, Fischbach W, F\u00f6lsch UR, Schreiber S . Interleukin-10 (\u2212819 C\/T) and TNF-A (\u2212308 G\/A) as risk factors for H. pylori-associated gastric MALT-lymphoma. Dig Dis Sci 2008; 53: 2007\u20132008.","journal-title":"Dig Dis Sci"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bcj201470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201470","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T22:52:32Z","timestamp":1672959152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,10]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10]]}},"alternative-id":["BFbcj201470"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2014.70","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,10]]},"assertion":[{"value":"6 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}